文献速递肾移植血液净化与透析

Medicare ESRD治疗选择模型与美国东南部肾移植及时可及性的关联

Association of Medicare's ESRD Treatment Choices Model with Timely Access to Kidney Transplantation in the Southeastern United States
RSS 订阅 · PubMed · J Am Soc Nephrol · 2026-10-28

该研究利用美国肾脏数据系统等链接数据,采用双重差分法比较ETC模型实施前后(2015-2019 vs 2021-2023)美国东南部三个州成人传统Medicare透析患者。结果显示ETC实施与及时转诊、评估启动、等待名单或活体供肾移植的校正差异增加均无统计学显著性。

要点

  • ETC实施与及时转诊、评估启动、等待名单或活体供肾移植的校正差异增加均无统计学显著性。
  • 血液透析机构直接影响的移植可及流程未见可检测变化,提示仅激励错位不足以解释ETC对移植的有限影响。
  • 两地区均观察到COVID时期移植转诊的显著延迟。

核心结论

  • ETC实施与美国东南部及时移植转诊、评估启动、等待名单或活体供肾移植的统计学显著改善无明确关联。

研究设计与样本

  • 利用美国肾脏数据系统、Early Steps to Transplant Access Registry和Scientific Registry of Transplant Recipients的链接数据。
  • 纳入佐治亚州、北卡罗来纳州和南卡罗来纳州在ETC实施前(2015-2019)和实施后(2021-2023)开始透析的成人传统Medicare受益人,共26,809人、706家机构。

主要发现

  • ETC实施与及时转诊的校正差异增加为3.58个百分点(95%CI,-1.30至8.45),相对对照机构。
  • ETC实施与评估启动的校正差异增加为8.52个百分点(95%CI,-1.42至18.45),相对对照机构。
  • ETC实施与等待名单或活体供肾移植的校正差异增加为3.61个百分点(95%CI,-0.26至7.48),相对对照机构。
  • 时间-事件分析与主要结果一致,且ETC和对照地区均存在COVID时期移植转诊的显著延迟。

临床怎么用

  • 对于美国东南部传统Medicare透析患者,ETC激励措施未显示明确改善移植可及流程,临床不应仅依赖财务激励来促进转诊和等待名单。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

J Am Soc Nephrol . 2026 Oct 28. doi: 10.1681/ASN.0000001300. Online ahead of print. ABSTRACT BACKGROUND: In 2021, Medicare's End-Stage Renal Disease Treatment Choices (ETC) Model randomly assigned 30% of U.S. dialysis facilities to financial incentives to increase home dialysis, waitlisting, and living-donor kidney transplantation. Early evaluations found no improvements in waitlisting or transplantation, but whether the ETC influenced upstream transplant access steps controlled by dialysis facilities remains unknown. METHODS: Using linked data from the United States Renal Data System, Early Steps to Transplant Access Registry, and Scientific Registry of Transplant Recipients, we assessed the association of ETC implementation with transplant referral within 1 year of dialysis initiation, evaluation initiation within 6 months of referral, waitlisting or living-donor transplantation within 2 years of dialysis initiation, and corresponding time-to-event outcomes. Difference-in-differences analyses compared outcomes at ETC versus control facilities among adult Traditional Medicare beneficiaries initiating dialysis in Georgia, North Carolina, and South Carolina before (2015-2019) and after (2021-2023) ETC implementation. Follow-up extended through December 2024 (referral, evaluation) and June 2025 (waitlisting, transplantation). RESULTS: Among 26,809 individuals in 706 facilities (mean [SD] age, 57 [13]; 43% female; 53% non-Hispanic Black; 46% dual Medicare/Medicaid eligible), ETC implementation was associated with adjusted differential increases in timely referral, evaluation start, and waitlisting or living-donor transplantation of 3.58 (95% CI, -1.30 to 8.45), 8.52 (95% CI, -1.42 to 18.45), and 3.61 (95% CI, -0.26 to 7.48) percentage points, respectively, relative to control facilities. Time-to-event analyses were consistent with primary results and substantial COVID-era delays in transplant referral across both ETC and control regions. CONCLUSIONS: ETC implementation was not associated with definitive evidence of statistically significant improvements in timely transplant referral, evaluation initiation, waitlisting, or living-donor transplantation in the Southeastern U.S. The absence of detectable changes in transplant access processes directly influenced by dialysis facilities suggests that incentive misalignment alone is unlikely to explain the ETC Model's limited impact on transplantation. PMID: 42949789 | DOI: 10.1681/ASN.0000001300

来源:PubMed · J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. PubMed · J Am Soc Nephrol:Association of Medicare's ESRD Treatment Choices Model with Timely Access to Kidney Transplantation in the Southeastern United States

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。